This is unpublished
Emily Liang
May 15, 2024

Emily Liang receives Hartwell Innovation Fund award

These awards support high-risk/high-reward, cancer-focused projects led by young investigators at Fred Hutch or UW Medicine.
Scroll for more
arrow icon
Back to top
Categories
Research

Dr. Emily Liang, fellow (Hematology and Oncology) has received the Hartwell Innovation Fund award (funding for this cycle provided by Swim Across America) for her project, “Characterization of the biological effects of prophylactic anakinra in patients undergoing CD19-targeted CAR T-cell therapy with lisocabtagene maraleucel.”

Liang and her mentor, Dr. Jordan Gauthier, have implemented the first investigator-initiated phase 2 clinical trial to evaluate prophylactic anakinra in preventing CRS and neurotoxicity after CD19 CAR T-cell therapy with lisocabtagene maraleucel (liso-cel; NCT04359784).

The Hartwell Innovation Fund will support novel correlative assays to define the biological effects of prophylactic anakinra in patients treated on this trial.